Literature DB >> 856725

Collagen prolyl hydroxylation in WI-38 fibroblast cultures: action of hydralazine.

K H Chen, M A Paz, P M Gallop.   

Abstract

The action of hydralazine on collagen prolyl hydroxylation was studied in a cell culture system using WI-38 fibroblasts. The prolyl hydroxylation level was determined by a method involving the digestion of collagen by bacterial collagenase and the examination of specific peptides. The presence of low concentrations of hydralazine (0.2 mM) in both "young" and "old" fibroblast cultures strongly inhibited collagen prolyl hydroxylation. The degree of inhibition was greater in serum-deficient cultures. No significant improvement in the degree of hydroxylation was observed by increasing either ascorbate or iron levels in the hydralazine-containing cultures in which hydroxylation was inhibited. Some of the reported side effects of hydralazine seen in patients might be related to its inhibitory effects on mixed function oxidative (MFO) hydroxylation systems. While the ascorbate dependence of the prolyl hydroxylase system of WI-38 decreased with the "age" of the culture, hydralazine inhibition of hydroxylation was dramatic with cultures of all "ages".

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856725     DOI: 10.1007/BF02615504

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  15 in total

1.  Rheumatic and febrile syndrome during prolonged hydralazine treatment.

Authors:  H P DUSTAN; R D TAYLOR; A C CORCORAN
Journal:  J Am Med Assoc       Date:  1954-01-02

2.  Hydroxyproline content determines the denaturation temperature of chick tendon collagen.

Authors:  J Rosenbloom; M Harsch; S Jimenez
Journal:  Arch Biochem Biophys       Date:  1973-10       Impact factor: 4.013

3.  Intracellular hydroxylation of non-helical protocollagen to form triple-helical procollagen and subsequent secretion of the molecule.

Authors:  J Uitto; D J Prockop
Journal:  Eur J Biochem       Date:  1974-04-01

4.  Inhibition of dopamine-beta-hydroxylase by hydralazine.

Authors:  T Z Liu; J T Shen; H F Loken
Journal:  Proc Soc Exp Biol Med       Date:  1974-01

5.  Intracellular collagen and protocollagen from embryonic tendon cells.

Authors:  S A Jimenez; P Dehm; B R Olsen; D J Prokop
Journal:  J Biol Chem       Date:  1973-01-25       Impact factor: 5.157

6.  Immunological studies of collagens modified by reaction with hydralazine.

Authors:  M A Paz; S Seifter
Journal:  Am J Med Sci       Date:  1972-04       Impact factor: 2.378

7.  Syndrome simulating acute disseminated lupus erythematosus: appearance after hydralazine (apresoline) therapy.

Authors:  N H SHACKMAN; A I SWILLER; M MORRISON
Journal:  J Am Med Assoc       Date:  1954-08-21

8.  Lupus erythematosus-like syndrome complicating hydralazine (apresoline) therapy.

Authors:  D J REINHARDT; J M WALDRON
Journal:  J Am Med Assoc       Date:  1954-08-21

9.  Collagen synthesized and modified by aging fibroblasts in culture.

Authors:  M A Paz; P M Gallop
Journal:  In Vitro       Date:  1975 Sep-Oct

10.  Late reaction to hydralazine (Apresoline) therapy.

Authors:  W B MANTER
Journal:  N Engl J Med       Date:  1954-05-13       Impact factor: 91.245

View more
  1 in total

1.  Practolol inhibits human skin fibroblast cell mat hydroxyproline accumulation.

Authors:  G R Elliott; H E Amos; K Miller; J W Bridges
Journal:  Agents Actions       Date:  1987-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.